Results 141 to 150 of about 70,452 (325)

Hyperuricemia and gout following pediatric renal transplantation [PDF]

open access: yes, 2018
Hyperuricemia and gout are common complications in adult renal transplant recipients. In pediatric recipients, however, hyperuricemia seems to be rare, but data are scarce. Thirty-two children (21 males, 11 females) were investigated for a median time of
Kemper, Markus   +2 more
core  

Association Between Metabolic Dysfunction and Gallstone Disease in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey

open access: yesJournal of Digestive Diseases, EarlyView.
We revealed a robust association between gallstone disease and a cluster of metabolic disorders, including obesity, non‐alcoholic fatty liver disease (NAFLD), diabetes mellitus, and hypertension. This association was consistently observed across sensitivity analyses and was especially evident in younger individuals and females.
Yong Feng Tang   +6 more
wiley   +1 more source

Hubungan Hiperurisemia, Obesitas Dan Riwayat Merokok Dengan Kejadian Hipertensi [PDF]

open access: yes, 2013
Hypertension is a common clinical problem. Hyperuricemia, obesity, and smoking history are assumed to have a relationship with hypertension in adult.
Ahmadi, A. P. (Adhytya)   +2 more
core  

Higher Atherogenic Index of Plasma Is Associated with Hyperuricemia: A National Longitudinal Study

open access: yesInternational Journal of Endocrinology
Background. The association between atherogenic index of plasma (AIP) and hyperuricemia remains indistinct. This study was aimed to examine the relationship between AIP and hyperuricemia among the middle-aged and the elderly Chinese population.
Feifei Xu   +5 more
doaj   +1 more source

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

open access: yesAllergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller   +13 more
wiley   +1 more source

Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria

open access: yesSahel Medical Journal, 2016
Background: Cardiovascular disease (CVD) is the leading cause of hospitalization and death in chronic kidney disease (CKD) patients. Hyperuricemia has emerged as one of the nontraditional cardiovascular risk factors. Studies have shown that hyperuricemia
Oluseyi A Adejumo   +3 more
doaj   +1 more source

Sex Differences in Body Composition and MASLD in Children With Overweight and Obesity

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To explore the relationships between body composition, indices of hepatic fibrosis, and sonographic evidence of hepatic steatosis in children with overweight and obesity. Methods One hundred and seventy individuals (age 12.7 ± 3.4 years, 38.2% boys) with overweight/obesity (BMI z‐score 2.02 ± 0.54) underwent bioelectrical impedance ...
Adi Uretzky   +11 more
wiley   +1 more source

Adolescents With Severe Obesity Had an Increased Risk of Reporting Symptoms That Indicated They Had Major Depression

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim This study aimed to compare the severity of depressive symptoms of Hong Kong adolescents with and without obesity and to explore the correlates of depressive symptoms using Patient Health Questionnaire‐9 (PHQ‐9). Methods Participants were recruited from the Paediatric Weight Control Clinic of Queen Mary Hospital or mainstream secondary ...
Geoffrey Chek‐Fei Yu   +3 more
wiley   +1 more source

Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Fotagliptin is a novel dipeptidyl peptidase‐4 inhibitor for glycaemic control in patients with type 2 diabetes (T2D). This trial aimed to assess the efficacy and safety of fotagliptin add‐on to metformin in patients with T2D. Materials and Methods In this phase 3 randomised, double‐blind, placebo‐controlled study, patients with T2D who had
Nan Yu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy